BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38377832)

  • 1. Economic burden for the Unified Health System attributable to excessive sodium consumption in Brazil.
    Guedes LFF; Vegi ASF; Felisbino-Mendes MS; Menezes MC; Meireles AL; Malta DC; Machado ÍE
    Public Health; 2024 Mar; 228():178-185. PubMed ID: 38377832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disability and costs of IHD attributable to the consumption of trans-fatty acids in Brazil.
    Parajára MDC; Fogal Vegi AS; Machado ÍE; Menezes MC; Verly-Jr E; Meireles AL
    Public Health Nutr; 2024 May; 27(1):e132. PubMed ID: 38726481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct and indirect costs attributed to alcohol consumption in Brazil, 2010 to 2018.
    de Freitas MG; Silva END
    PLoS One; 2022; 17(10):e0270115. PubMed ID: 36282815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Burden of disease and direct costs to the health system attributable to high body mass index in Brazil.
    Rocha LP; Machado ÍE; Fogal AS; Malta DC; Velasquez-Melendez G; Felisbino-Mendes MS
    Public Health; 2024 Jun; 233():121-129. PubMed ID: 38870844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic burden of cancer attributable to overweight in the Brazilian Unified Health System.
    de Carvalho JB; Giannichi B; Ferrari G; Tomita LY; Paiva LDS; Adami F; Rezende LFM
    J Cancer Policy; 2022 Sep; 33():100345. PubMed ID: 35724958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modelling the effect of compliance with WHO salt recommendations on cardiovascular disease mortality and costs in Brazil.
    Nilson EAF; Metlzer AB; Labonté ME; Jaime PC
    PLoS One; 2020; 15(7):e0235514. PubMed ID: 32645031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The economic burden of overweight and obesity in Brazil: perspectives for the Brazilian Unified Health System.
    Ferrari G; Giannichi B; Resende B; Paiva L; Rocha R; Falbel F; Rache B; Adami F; Rezende LFM
    Public Health; 2022 Jun; 207():82-87. PubMed ID: 35569435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health economic impacts associated with the consumption of sugar-sweetened beverages in Brazil.
    Leal JSV; Fogal AS; Meireles AL; Cardoso LO; Machado ÍE; de Menezes MC
    Front Nutr; 2022; 9():1088051. PubMed ID: 36601075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Costs of cancer attributable to excess body weight in the Brazilian public health system in 2018.
    Corrêa Ferreira da Silva R; Bahia LR; Machado da Rosa MQ; Malhão TA; Mendonça EP; Rosa RDS; Araújo DV; Maya Moreira LG; Schilithz AOC; Diogenes Melo MEL
    PLoS One; 2021; 16(3):e0247983. PubMed ID: 33705455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Costs of obesity attributable to the consumption of sugar-sweetened beverages in Brazil.
    da Silva BF; de Arruda Neta ADCP; de Alencar Rodrigues RE; de Araújo JM; Moreira PVL; Ferreira FELL; de Toledo Vianna RP; da Silva Neto JM; de Carli E; de Lima RLFC
    Sci Rep; 2024 Jun; 14(1):13936. PubMed ID: 38886385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic burden of colorectal and breast cancers attributable to lack of physical activity in Brazil.
    Rezende LFM; Ferrari G; Bahia LR; Rosa RDS; da Rosa MQM; de Souza RC; Lee DH; Giovannucci E; Eluf-Neto J
    BMC Public Health; 2021 Jun; 21(1):1190. PubMed ID: 34158014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The projected economic burden of non-communicable diseases attributable to overweight in Brazil by 2030.
    Giannichi B; Nilson E; Ferrari G; Rezende LFM
    Public Health; 2024 May; 230():216-222. PubMed ID: 38579649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The costs of overweight and obesity-related diseases in the Brazilian public health system: cross-sectional study.
    Bahia L; Coutinho ES; Barufaldi LA; Abreu Gde A; Malhão TA; de Souza CP; Araujo DV
    BMC Public Health; 2012 Jun; 12():440. PubMed ID: 22713624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health impacts caused by excessive sodium consumption in Brazil: results of the GBD 2019 study.
    Guedes LFF; Felisbino-Mendes MS; Vegi ASF; Meireles AL; Menezes MC; Malta DC; Machado ÍE
    Rev Soc Bras Med Trop; 2022; 55(suppl 1):e0266. PubMed ID: 35107510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost of diseases related to alcohol consumption in the Brazilian Unified Health System.
    Coutinho ES; Bahia L; Barufaldi LA; Abreu Gde A; Malhão TA; Pepe CR; Araujo DV
    Rev Saude Publica; 2016 Jun; 50():. PubMed ID: 27305403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease and Economic Burden of Hospitalizations Attributable to Diabetes Mellitus and Its Complications: A Nationwide Study in Brazil.
    Rosa MQM; Rosa RDS; Correia MG; Araujo DV; Bahia LR; Toscano CM
    Int J Environ Res Public Health; 2018 Feb; 15(2):. PubMed ID: 29419786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The direct and indirect costs of cardiovascular diseases in Brazil.
    de Araújo JM; Eufrosino de Alencar Rodrigues R; da Costa Pereira de Arruda Neta A; Leite Lima Ferreira FE; Lira Formiga Cavalcanti de Lima R; Pinheiro de Toledo Vianna R; Vasconcelos Leitão Moreira L; Moreira da Silva Neto J; Moreira PVL
    PLoS One; 2022; 17(12):e0278891. PubMed ID: 36548305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimated costs of hospitalization due to coronary artery disease attributable to familial hypercholesterolemia in the Brazilian public health system.
    Bahia LR; Rosa RS; Santos RD; Araujo DV
    Arch Endocrinol Metab; 2018 Jun; 62(3):303-308. PubMed ID: 29791657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating the health and economic effects of the voluntary sodium reduction targets in Brazil: microsimulation analysis.
    Nilson EAF; Pearson-Stuttard J; Collins B; Guzman-Castillo M; Capewell S; O'Flaherty M; Jaime PC; Kypridemos C
    BMC Med; 2021 Sep; 19(1):225. PubMed ID: 34583695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Annual Direct Medical Costs of Diabetic Foot Disease in Brazil: A Cost of Illness Study.
    Toscano CM; Sugita TH; Rosa MQM; Pedrosa HC; Rosa RDS; Bahia LR
    Int J Environ Res Public Health; 2018 Jan; 15(1):. PubMed ID: 29316689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.